DURARET Trademark

Trademark Overview


On Friday, January 17, 2003, a trademark application was filed for DURARET with the United States Patent and Trademark Office. The USPTO has given the DURARET trademark a serial number of 78204624. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, September 16, 2007. This trademark is owned by Ligand Pharmaceuticals Incorporated. The DURARET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of skin related diseases, cancer and pre-cancerous conditions, disorders of the eye, cardiovascular disorders, disorders related to the modulation apoptosis, inflammatory diseases and neurodegenerative diseases

General Information


Serial Number78204624
Word MarkDURARET
Filing DateFriday, January 17, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, September 16, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 10, 2004

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of skin related diseases, cancer and pre-cancerous conditions, disorders of the eye, cardiovascular disorders, disorders related to the modulation apoptosis, inflammatory diseases and neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 5, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLigand Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 921211117

Party NameLigand Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 921211117

Trademark Events


Event DateEvent Description
Monday, December 10, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, December 7, 2007ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 14, 2007EXTENSION 4 GRANTED
Wednesday, February 14, 2007EXTENSION 4 FILED
Wednesday, February 14, 2007TEAS EXTENSION RECEIVED
Saturday, September 9, 2006EXTENSION 3 GRANTED
Friday, August 4, 2006EXTENSION 3 FILED
Friday, August 4, 2006TEAS EXTENSION RECEIVED
Tuesday, February 7, 2006EXTENSION 2 GRANTED
Tuesday, February 7, 2006EXTENSION 2 FILED
Tuesday, February 7, 2006TEAS EXTENSION RECEIVED
Friday, June 10, 2005EXTENSION 1 GRANTED
Friday, June 10, 2005EXTENSION 1 FILED
Friday, June 10, 2005TEAS EXTENSION RECEIVED
Tuesday, March 15, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 18, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 8, 2004EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 1, 2004PAPER RECEIVED
Thursday, March 11, 2004EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 10, 2004PUBLISHED FOR OPPOSITION
Wednesday, January 21, 2004NOTICE OF PUBLICATION
Tuesday, December 16, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 12, 2003PAPER RECEIVED
Saturday, June 28, 2003NON-FINAL ACTION E-MAILED
Saturday, June 28, 2003ASSIGNED TO EXAMINER
Wednesday, June 25, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 2, 2003PAPER RECEIVED